Mounjaro Sickness and Diarrhoea: What Happens, Why, and What Helps

Nausea and loose stools are common, especially in the first weeks and after each dose increase — the NHS lists both as known tirzepatide side effects.
Symptoms are usually mild to moderate and tend to ease as your body adjusts; eating smaller, lower-fat meals can help.
Severe or persistent stomach pain that spreads to your back, with or without vomiting, requires urgent medical attention, seek help promptly.
You can report any suspected side effect through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Nausea and diarrhoea are the most commonly reported side effects of Mounjaro (tirzepatide), and yes, they can genuinely disrupt your first few weeks. Most people find the sickness settles as the body adjusts; diarrhoea tends to be milder and shorter-lived than nausea for most. These medicines are prescription-only and started under clinical supervision — the full side-effect picture is broader than the gut symptoms, but the stomach effects are what patients ask about most. A prescriber assesses your medical history before treatment begins, and that assessment is where questions like these belong.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How nausea and diarrhoea develop on Mounjaro, and what actually helps

Your first pen has arrived, and then the nausea starts

The tracking notification pings, DPD delivers a plain, unbranded box, and inside is your first Mounjaro KwikPen. For many people the first injection passes without incident. For others, within a day or two, a wave of nausea arrives, sometimes accompanied by looser stools or an urgency to the bathroom they weren't quite expecting.

This isn't a sign something has gone wrong. Tirzepatide activates receptors in the gut that slow gastric emptying and signal fullness to the brain. That slowing is exactly the mechanism that reduces appetite, but it's also why your stomach may feel unsettled, particularly while your body is calibrating to a dose it hasn't encountered before. The NHS patient information page for tirzepatide confirms nausea, diarrhoea, vomiting and constipation among the most commonly reported effects.

If you want to understand more about why Mounjaro sickness happens and what drives it, the mechanism becomes a lot clearer when you look at how tirzepatide interacts with the gut. That's why the titration schedule exists. The starting dose is about settling your system, not therapeutic weight loss yet, so the prescriber moves you up gradually rather than all at once. Eating smaller portions, avoiding high-fat or very rich food, and staying hydrated all have practical evidence behind them for reducing GI symptoms. So does eating slowly and not lying down for an hour after a meal.

Most people find things meaningfully better by week three or four at a given dose. That isn't universal, but it's the pattern our clinical team sees most often.

Can Mounjaro cause sickness and diarrhoea at every dose, or just the beginning?

Both, potentially. The honest answer is that GI symptoms can resurface whenever the dose increases, even in someone who had no trouble at lower levels. The gut is adjusting to a new signal strength each time. For most people, the nausea of 5mg is less disruptive than 2.5mg was, because some tolerance has built up, but that's not guaranteed.

Diarrhoea on Mounjaro is generally reported less often than nausea. When it does occur, it's usually short-lived, appearing in the first day or two after an injection and resolving without treatment. Staying hydrated matters: repeated episodes of diarrhoea or vomiting can lead to dehydration, which in turn can stress the kidneys. That's not a reason to stop without speaking to your prescriber, it's a reason to keep fluid intake up and flag anything that isn't resolving.

A few practical approaches people find helpful: ginger tea, plain crackers, cold foods (which tend to have a less strong smell), and avoiding eating right before the injection. Our page on sickness from Mounjaro goes into these approaches in more detail, alongside the kind of practical suggestions that come up in conversations about managing these symptoms. Your prescriber and the Patient Information Leaflet are the right source for personal guidance.

Constipation is also possible, sometimes alternating with looser stools, because slowed gastric emptying affects the whole digestive transit. Fibre, hydration and keeping active help most people here too.

When to get medical help: the symptoms that need prompt attention

Most GI symptoms from Mounjaro are unpleasant but not dangerous. Some, though, need prompt medical assessment.

Acute pancreatitis is a known, infrequent but serious risk with GLP-1 receptor agonists including tirzepatide. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting pancreatitis across this class of medicine. The symptom to act on is severe stomach pain that persists and radiates toward the back, particularly if it comes with vomiting that doesn't settle. Don't wait this one out. Call 111, go to urgent care, or call 999 if the pain is severe and sudden.

Also seek prompt help for: signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing); gallbladder symptoms (sharp pain in the upper right abdomen, especially after eating); or if you cannot keep any fluids down for more than 24 hours, since dehydration can become a clinical problem faster than people expect.

You can report any suspected side effect (whether it's significant or just something that felt unusual) through the MHRA Yellow Card scheme. This matters: it's how the safety picture of newer medicines gets built up over time, and Mounjaro still carries a Black Triangle (▼) flag indicating additional monitoring is in place.

If you're on treatment with nume and something isn't feeling right, our support team is available seven days a week, you won't be left waiting for a Monday morning.

Suitability, sickness history and what a prescriber weighs up

Some people are more prone to GI side effects than others, and a thorough consultation is the place to surface that. Someone with a history of gastroparesis, inflammatory bowel disease or certain other GI conditions may not be a suitable candidate; someone who has had severe nausea on another GLP-1 medicine will have that factored in. This is exactly why clinical review happens before a prescription is written, not as a formality.

Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above where a weight-related condition is present, alongside a reduced-calorie diet and increased activity. Lower BMI thresholds may apply for some ethnic backgrounds under UK clinical guidance. But eligibility on paper doesn't mean the medicine is right for every individual who fits the criteria, that judgement belongs to the prescriber, who reviews the whole picture.

If you're considering treatment and wondering whether your stomach will tolerate it, that's a conversation worth having before you start. Our prescribers discuss suitability and side effects as part of the consultation, check your eligibility and begin that conversation here. There's no obligation, and the consultation is free.

For a broader overview of how Mounjaro works and what treatment involves, or to read about the process of accessing it through a regulated UK pharmacy, those pages cover the wider picture.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions